These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9793590)
41. Cytarabine: distribution in ventricular cerebrospinal fluid after lumbar injection. Przuntek H; Breithaupt H J Neurol; 1981; 226(1):73-6. PubMed ID: 6181218 [No Abstract] [Full Text] [Related]
42. Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements. Brandner S; Thaler C; Lewczuk P; Lelental N; Buchfelder M; Kleindienst A Eur Neurol; 2013; 70(3-4):189-94. PubMed ID: 23969528 [TBL] [Abstract][Full Text] [Related]
43. High-dose methotrexate in acute lymphocytic leukemia. Freeman AI; Wang JJ; Sinks LF Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510 [TBL] [Abstract][Full Text] [Related]
44. Successful large-volume cerebrospinal fluid aspiration for an accidental overdose of intrathecal cytarabine. Makar G; Al-Zubaidi M; Amar S; Feiz-Erfan I; Mehta D Med Oncol; 2013 Jun; 30(2):525. PubMed ID: 23463468 [TBL] [Abstract][Full Text] [Related]
45. Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. Blaney SM; Poplack DG; Godwin K; McCully CL; Murphy R; Balis FM J Clin Oncol; 1995 Jan; 13(1):177-9. PubMed ID: 7799017 [TBL] [Abstract][Full Text] [Related]
46. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model. Sandberg DI; Peet MM; Johnson MD; Cole P; Koru-Sengul T; Luqman AW J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032 [TBL] [Abstract][Full Text] [Related]
47. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970 [TBL] [Abstract][Full Text] [Related]
48. Active transport of methotrexate from cerebrospinal fluid in humans. Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786 [TBL] [Abstract][Full Text] [Related]
49. Prediction of methotrexate CNS distribution in different species - influence of disease conditions. Westerhout J; van den Berg DJ; Hartman R; Danhof M; de Lange EC Eur J Pharm Sci; 2014 Jun; 57():11-24. PubMed ID: 24462766 [TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid neurotransmitter changes during the perioperative period in patients undergoing total knee replacement: a randomized trial. Buvanendran A; Kroin JS; Della Valle CJ; Moric M; Tuman KJ Anesth Analg; 2012 Feb; 114(2):434-41. PubMed ID: 22156332 [TBL] [Abstract][Full Text] [Related]
51. Pressure-absorption responses to the infusion of fluid into the spinal cord central canal of kaolin-hydrocephalic cats. Nakamura S; Camins MB; Hochwald GM J Neurosurg; 1983 Feb; 58(2):198-203. PubMed ID: 6848676 [TBL] [Abstract][Full Text] [Related]
52. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer]. Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276 [TBL] [Abstract][Full Text] [Related]
53. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium. Bleyer WA Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743 [No Abstract] [Full Text] [Related]
54. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination]. Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217 [TBL] [Abstract][Full Text] [Related]
55. Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis: a phase I study with pharmacokinetic data. Gwak HS; Lim HS; Shin SH; Yoo H; Han JY; Kim HT; Yun T; Lee JS; Lee SH Am J Clin Oncol; 2013 Oct; 36(5):491-9. PubMed ID: 22781384 [TBL] [Abstract][Full Text] [Related]
56. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia. Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310 [TBL] [Abstract][Full Text] [Related]
57. Liposomal cytarabine in cerebrospinal fluid. Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172 [No Abstract] [Full Text] [Related]
58. Safety of intra-cerebrospinal fluid chemotherapy in onco-haematological patients: a retrospective analysis of 627 interventions. Pardo-Moreno J; Fernández C; Arroyo R; Ruiz-Ocaña C; Aláez C; Cuadrado ML J Neurooncol; 2015 Nov; 125(2):351-8. PubMed ID: 26342710 [TBL] [Abstract][Full Text] [Related]
59. [Pharmacokinetics of ACNU in cerebrospinal fluid]. Imagawa K; Kawasaki M; Toda I; Hayashi M; Asai A; Nomura T Gan To Kagaku Ryoho; 1982 Sep; 9(9):1543-8. PubMed ID: 6964049 [TBL] [Abstract][Full Text] [Related]
60. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. Chamberlain MC; Kormanik PA; Barba D J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]